Current Month 2005
Article Features
  Study Finds Little Evidence That Having Been Breast-Fed Affects Cancer Development in Adults
Model Predicts Risk of Breast Cancer for Young Women Treated for Hodgkin Lymphoma
Questionnaire Helps Identify Women at Risk of Inherited Breast or Ovarian Cancer
Male Reactions to a Breast Cancer Diagnosis
Microarray Technology Could Help Predict Response to Adjuvant Therapy for Breast Cancer
Breast Cancer Patients Turn to Reflexology for Comfort
Smoking Associated with up to 40 Percent Increased Risk of Breast Cancer
Work Absence after Breast Cancer Diagnosis
Black Women with Early Stage Breast Cancer Less Likely to Receive Full Course of Chemotherapy
Genetic Testing for Breast Cancer Could Benefit Minorities But is Underused
Herceptin Following Chemotherapy Significantly Reduces Risk of Breast Cancer Recurrence
Study Finds New Type of Silicone Implant Offers More Natural Looking Breasts, Low Complication Rate
Breast Conserving Treatment an Option for Women with Implants
Curcumin Halts Spread of Breast Cancer in Mice
MRI Helps Doctors Select Best Treatment for Early Breast Cancer
Other Illnesses Play Role in Difference in Breast Cancer Survival Rates Between Blacks and Whites
Side Effects Cause Some Breast Cancer Patients to Skip Hormone Treatment


Panel Calls for Expanded Role of Needle Biopsies, MRI and Less Invasive Procedures

Physicians should strive to replace traditional, invasive procedures for diagnosing breast cancer with proven, less-invasive diagnostic methods, according to an international panel of breast cancer experts convened at the Keck School of Medicine of the University of Southern California.

In a consensus paper published in the Journal of the American College of Surgeons, 23 leading surgeons, radiologists, pathologists and oncologists say minimally invasive needle breast biopsies and sentinel node biopsies should be performed more routinely than they currently are. In the case of breast biopsies, the experts say open surgical biopsies should almost never be done, though experts estimate that nearly a third of the 1.7 million breast biopsies performed in the nation are still done this way.

"New technology has changed the face of breast cancer," said consensus panel chair Melvin J. Silverstein, M.D., professor of surgery and Henrietta C. Lee Chair in Breast Cancer Research at the Keck School of Medicine. "We can do things much less invasively than ever before, and doctors and women need to take advantage of these advances whenever they can."

The panel concluded that minimally invasive needle breast biopsy is "the procedure of choice for image-detected breast abnormalities" and keeps the majority of women with non-cancerous findings out of the operating room. For those who do have breast cancer, needle biopsies allow for better pre-operative planning for breast surgery.

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon